Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News CytoSorbents Corporation CTSO

Healthcare Medical Devices
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. The company’s flagship product is CytoSorb, an extracorporeal blood purification cartridge for the treatment of massive... see more

Current News (NDAQ:CTSO)

CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025

PR Newswire December 10, 2025

Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London

PR Newswire November 17, 2025

CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update

PR Newswire November 13, 2025

CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London

PR Newswire November 11, 2025

CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights

PR Newswire October 30, 2025

In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer

PR Newswire October 28, 2025

CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen

PR Newswire September 29, 2025

CytoSorbents Provides DrugSorb-ATR Regulatory Update

PR Newswire September 16, 2025

CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day

PR Newswire September 8, 2025
View More News ››

Opinion & Analysis (NDAQ:CTSO)

Maxim raises target price of biotech company

The Life Sciences Report August 17, 2017

Four small-cap medtech primed for outsize returns: Zacks' Brian Marckx

The Life Sciences Report July 15, 2015
View More Opinion ››

Bullboard Posts (NDAQ:CTSO)

RE:great future

Im already in and questioning the valuation.  For a company valued well north of 500 M CAD, the scientific backing is looking as...
SouthernTierTom - September 15, 2018

great future

no activety  on this board but if any one happens to read this it is not to late to invest in CTSO. Great things are about to happen...
robertwfb - September 2, 2018

NC4

http://img15.hostingpics.net/pics/178152CTSOdown.png
Stocktree - June 29, 2016

Nice cartoon 3

Stocktree - June 29, 2016

Nice cartoon 2

Stocktree - June 29, 2016

Nice cartoon

Stocktree - June 29, 2016
View more Bullboard ››

Green Bridge Metals Corporation

Green Bridge Metals Corporation

Green Bridge Metals Corporation engages in the acquisition, exploration, and development of mining projects in Canada. The ...
View More »

Podcasts